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Congenital chloride diarrhea is an autosomal recessive disease caused by mutations
in the intestinal lumenal membrane Cl−/HCO− exchanger, SLC26A3. We report here3
the novel SLC26A3 mutation G393W in a Mexican child, the first such report in
a patient from Central America. SLC26A3 G393W expression in Xenopus oocytes
exhibits a mild hypomorphic phenotype, with normal surface expression and moderately
reduced anion transport function. However, expression of HA-SLC26A3 in HEK-293 cells
reveals intracellular retention and greatly decreased steady-state levels of the mutant
polypeptide, in contrast to peripheral membrane expression of the wildtype protein.
Whereas wildtype HA-SLC26A3 is apically localized in polarized monolayers of filter-
grown MDCK cells and Caco2 cells, mutant HA-SLC26A3 G393W exhibits decreased
total polypeptide abundance, with reduced or absent surface expression and sparse
punctate (or absent) intracellular distribution. The WT protein is similarly localized in
LLC-PK1 cells, but the mutant fails to accumulate to detectable levels. We conclude
that the chloride-losing diarrhea phenotype associated with homozygous expression
of SLC26A3 G393W likely reflects lack of apical surface expression in enterocytes,
secondary to combined abnormalities in polypeptide trafficking and stability. Future
progress in development of general or target-specific folding chaperonins and correctors
may hold promise for pharmacological rescue of this and similar genetic defects in
membrane protein targeting.
Keywords: chloride bicarbonate exchange, down-regulated in adenoma, NaCl reabsorption, Xenopus oocyte,
MDCK cells
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Introduction
Congenital chloride diarrhea (CLD; OMIM# 214700) is a rare
chronic secretory diarrhea of autosomal recessive inheritance
associated with polyhydramnios and premature birth. Postnatal
clinical diagnosis is based on the presentation of dehydration and
failure to thrive in the setting of hypokalemic metabolic alkalosis,
with acidic stool pH and elevated stool chloride (>90mM)
measured after normalization of systemic volume status and
serum electrolytes. Untreated disease leads to chronic systemic
volume depletion, nephrocalcinosis and impaired renal function
sometimes progressing to end-age renal disease. Additional
clinical problems noted later in life have included intestinal
inflammation, hyperuricemia, inguinal hernia, and impaired
male fertility (Wedenoja et al., 2011).
CLD is caused by mutations in the gene encoding SLC26A3
(Hoglund et al., 1996), with 21 exons spanning ∼38 kb on
chromosome 7q31.1. The single ∼2900 bp mRNA SLC26A3
transcript encodes a polypeptide of 764 amino acids (aa) in
length. The SLC26A3 polypeptide includes a short N-terminal
cytoplasmic domain, a ∼500 aa polytopic transmembrane
domain of unknown structure that has been tentatively modeled
on the transmembrane domain of the ecCLC Cl−/H+ antiporter
(Ohana et al., 2011), and a ∼220 aa C-terminal cytoplasmic
region comprising mainly the Sulfate Transporter and Anti-
Sigma Factor Antagonist (STAS) domain (Sharma et al., 2011).
SLC26A3 mediates Cl−/HCO−3 exchange across the apical
membrane of enterocytes, coordinating with Na+/H+ exchanger
NHE3 (and in some conditions, NHE8, Xu et al., 2012) to carry
out electroneutral NaCl reabsorption from the intestinal lumen
(Zachos et al., 2005; Kato and Romero, 2011).
CLD incidence is as high as 1 in 3200 births in Kuwait
and other Persian Gulf countries, associated with high rates
of consanguinity. Moderately elevated rates have also been
noted in Finland (1 in 30–40,000 births), and Poland (1 in
200,000 births). Isolated cases have been reported in many
other countries (Wedenoja et al., 2011). Here we report a novel
missense mutation in the transmembrane domain of SLC26A3,
in the context of the first SLC26A3-linked CLD case reported
from Mexico. The mutant protein as expressed in Xenopus
oocytes accumulates to normal levels and exhibits only modest
loss-of-function. However, when expressed in HEK-293 cells,
MDCK cells, LLC-PK1 cells, or Caco2 cells, the mutant protein
accumulates to low or undetectable levels, with reduced or
absent cell surface expression. We conclude that the G393W
missense substitution likely causes CLD by destabilization and/or
mistargeting of the SLC26A3 polypeptide.
Methods
Genomic DNA Preparation and Sequencing
Blood was obtained from the patient and his parents and
subjected to genetic analysis according to protocols approved by
the Committees on Clinical Investigation of the Hospital Infantil
de Mexico Federico Gomez, of Beth Israel Deaconess Medical
Center, and of Boston Children’s Hospital. Whole blood sent
from Mexico City to Boston was subjected to genomic DNA
extraction using the QIAamp DNA Blood Mini Kit (Qiagen,
Hilden, Germany). Oligonucleotide primers for amplification
of exons and flanking regions of the candidate disease
gene SLC26A3/DRA were designed with Primer3 software
(SimGene.com), and are available upon request. Amplimers were
subjected to Sanger sequencing on both strands.
cRNA Transcription and Expression in Xenopus
Oocytes
SLC26A3 cDNA in Xenopus oocyte expression vector pBF
(Chernova et al., 2003) was subjected to missense mutagenesis
to generate the G393W mutant cDNA, using the four-primer
polymerase chain reaction (PCR) method (oligonucleotide
primer sequences available upon request). Capped SLC26A3
cRNA was transcribed from linearized plasmid DNA template
with SP6 RNA polymerase (Megascript, Ambion, Austin, TX)
and purified with an RNeasy mini-kit (Qiagen, Germantown,
MD). cRNA concentration (A260) was measured by Nanodrop
spectrometer (ThermoFisher, Waltham, MA), and integrity was
confirmed by formaldehyde agarose gel electrophoresis. Mature
female Xenopus laevis frogs (Dept. of Systems Biology, Harvard
Medical School) were subjected to partial ovariectomy under
hypothermic tricaine anesthesia following protocols approved
by the Institutional Animal Care and Use Committee (IACUC)
of Beth Israel Deaconess Medical Center. Stage V-VI oocytes
were prepared by overnight incubation of ovarian fragments in
1.5mg/ml collagenase B (Alfa Aesar, Ward Hills, MA) dissolved
in MBS (in mM: 88 NaCl, 1 KCl, 2.4 NaHCO3, 0.82 MgSO4,
0.33 Ca(NO3)2, 0.41 CaCl2, and 10 HEPES, pH 7.40), followed
by a 20min rinse in Ca2+-free MBS, with subsequent manual
selection and defolliculation as needed. Oocytes were injected on
the same day with cRNA (10 ng or as indicated), and maintained
72 h at 17.5◦C in MBS containing 10µg/mL gentamicin until
used for experiments. As uninjected and water-injected oocytes
did not differ in anion transport at 72 h post-injection (data not
shown), uninjected oocytes were used as controls for the current
experiments.
36Cl− Influx Assays in Xenopus Oocytes
Unidirectional 36Cl− influx studies were carried out for periods
of 30min in 148µL ND-96 (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2,
1 MgCl2, and 5 HEPES, pH 7.40) containing 2µL carrier-
free 260mM Na36Cl (0.25µCi), resulting in total bath [Cl−]
of 103.6mM. In Cl−-substituted solutions, NaCl was replaced
mole-for-mole with NaHCO3 or Na cyclamate. Cl
− salts of K+,
Ca2+, and Mg2+ were substituted on an equimolar basis with
the corresponding gluconate salts as needed. All 36Cl− influx
solutions contained 10µM bumetanide to block Cl− flux via
native oocyte NKCC1. Uptake was linear over 30min under these
conditions.
Oocyte 36Cl− influx experiments were terminated with four
washes in ice-cold isotonic Na cyclamate solution. Washed
oocytes were individually lysed in 150µL 2% sodium dodecyl
sulfate (SDS). Triplicate 10µL aliquots of the influx solution were
used to calculate specific activity of radiolabeled substrate anions.
Oocyte anion uptake was calculated from cpm values of washed
oocytes and from bath specific activity.
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36Cl− Efflux Assays in Xenopus Oocytes
Individual oocytes were injected with 50 nl of 260mM Na36Cl
(6.25 nCi, 20,000–24,000 cpm). Following a 5–10min recovery
period in Cl−-free cyclamate solution, the eﬄux assay was
initiated by transfer of individual oocytes to 6ml borosilicate
glass tubes, each containing 1ml eﬄux solution with the
indicated anions and 10µM bumetanide. At intervals of 3min,
0.95ml of this eﬄux solution was removed for scintillation
counting and replaced with an equal volume of fresh eﬄux
solution. Following completion of the assay with a final eﬄux
period in Cl−-free cyclamate solution, each oocyte was lysed in
150µL of 2% SDS. Samples were counted for 3–5min such that
the magnitude of 2SD was <5% of the sample mean.
Eﬄux data was plotted as the natural logarithm (ln) of the
quantity (% cpm remaining in the oocyte) vs. time. Eﬄux rate
constants for 36Cl− were measured from linear fits to data from
the last three time points sampled within each experimental
period. For each experiment, uninjected oocytes from the same
frog were subjected to parallel measurements with cRNA-injected
oocytes. Oocytes with <15% of injected 36Cl− remaining at the
end of the assay were excluded from analysis.
Confocal Immunofluorescence Microscopy of
Xenopus Oocytes
Oocytes were injected with 10 ng cRNA encoding wild-type or
mutant SLC26A3 bearing at their N-termini the HA epitope tag
(YPYDVPDYA). Uninjected oocytes and oocytes injected with
cRNA 3 days prior were fixed at 4◦C for 30min in phosphate-
buffered saline (PBS) containing 1.5% paraformaldehyde (PFA),
then washed three times in PBS supplemented with 0.002%
sodium azide, exposed to 1% SDS in 1x PBS for 5min,
and then blocked in PBS with 1% bovine serum albumin
(BSA) and 0.05% saponin for 1 h at 4◦C. Oocytes were then
incubated 2 h at 4◦C with rabbit monoclonal anti-HA peptide
(dilution 1:1600; Cell Signaling, Danvers, MA), followed by
three washes with 1% PBS-BSA. Oocytes were then incubated
for 2 h with Cy3-conjugated secondary donkey anti-rabbit Ig
(dilution 1:1600; Jackson Immunochemicals, West Grove, PA)
and again thoroughly washed in PBS-BSA. Oocytes were aligned
in uniform orientation along a plexiglass groove and sequentially
imaged through the 10X objective of a Zeiss LSM510 laser
scanning confocal microscope, using the 543-nm laser line
at 512 × 512 resolution, at constant filter, gain, and pinhole
settings.
Polypeptide abundance at or near each oocyte surface was
estimated by quantitation of specific fluorescence intensity (FI) at
the periphery of one quadrant of an equatorial focal plane (Image
J v. 1.38, National Institutes of Health). The mean background FI
of uninjected oocytes was subtracted from each single oocyte FI.
Normalized means and standard errors were calculated for each
group. Images of median intensity were selected from each group
for presentation.
SLC26A3 Expression in Mammalian Cells
Wildtype and G393W mutant SLC26A3 cDNAs encoding an
N-terminal HA epitope tag were subcloned into eukaryotic
expression vector pcDNA3. All cells were grown at 37◦C in
humidifed 5% CO2. HEK-293T cells maintained in DMEM
+ 10% calf serum were grown to 80–90% confluency on
24mm glass coverslips. MDCK cells maintained in DMEM
+ 10% calf serum were grown to 80–90% confluency or
to full confluency on 12mm Transwell polycarbonate inserts
(Corning Life Sciences, Lowell, MA) placed in 12-well plates.
Cells in each well were transfected with 1µg cDNA using
Lipofectamine 2000 (Life Technologies, Carlsbad, CA). Caco2
cells maintained in high glucose DMEM supplemented with 10%
FBS and 15mM HEPES, pH 7.4, were grown to low confluency
or near-confluency on glass coverslips, or to confluency on
Transwell inserts, and transfected with 1µg cDNA using
either Lipofectamine 2000 or X-Fect (Takara ClonTech). LLC-
PK1 cells maintained in Medium 199 supplemented with L-
glutamine, 2.2 g/L sodium bicarbonate, and 3% FBS were grown
to near-confluency on glass coverslips previously coated with
Synthemax (Corning Life Sciences, Tewksbury, MA). 106 cells
were transfected with 2µg cDNA with the Amaxa Nucleofector
II (Lonza, Allendale, NJ) using Kit L and Program T-020, as
per manufacturer’s protocol. After 24–72 h, PBS-rinsed cells were
fixed 10min in 2% paraformaldehyde, then washed three times
with phosphate-buffered saline (PBS: 140mM NaCl, 20mM
NaHPO4, pH 7.40). If not processed immediately, fixed cells
were stored at 4◦C until further use. Rabbit anti-HA was from
Cell Signaling Technologies. Mouse anti-gp135/podocalyxin was
a gift of George Ojakian. Rabbit anti-α1-Na,K-ATPase was
from Santa Cruz Biotechnology. Mouse anti-α1-Na,K-ATPase
was from Developmental Studies Hybridoma Bank (Iowa City,
IA). Anti-E-Cadherin was from BD Transduction Laboratories
(San Jose, CA). F-actin was detected with AlexaFluor647-
phalloidin (Molecular Probes). Nuclear DNA was detected with
DAPI or DRAQ-5 (Thermo Scientific, Life Technologies) as
indicated.
SLC26A3 Immunoblot
HEK-293 cells transiently transfected as above with HA-
SLC26A3 cDNA were maintained for 24 h, then lysed in RIPA
buffer containing 150mM NaCl, 50mM Tris pH 7.4, 1% NP-
40, 1% Na deoxycholic acid, and 0.1% SDS. The cell lysate was
cleared by centrifugation at 4◦C, and protein concentration of the
cleared lysate was measured by BCA assay (Pierce Biotechnology,
Rockford, IL). 50µg total protein in 1X sample loading buffer
supplemented with 5% β-mercaptoethanol denatured for 5min at
95◦C, then loaded into each lane of a precast 7.5% polyacrylamide
gel (BioRad Laboratories, Hercules, CA) and fractionated by
SDS-PAGE. Semi-dry transfer onto a PVDF membrane was
followed by blocking the membrane for 1 h at 4◦C in 1X
PBS containing 5% nonfat dry milk. The membrane was
incubated overnight at 4◦C in with rabbit monoclonal anti-HA
peptide (1:1000; Cell Signaling, Danvers, MA), washed in PBS
containing 1% Tween, then incubated in horseradish peroxidase
(HRP)-coupled goat-anti-rabbit Ig (1:2000; Cell Signaling). After
thorough washing, the membrane was exposed for 1min to
enhanced chemiluminescence (ECL) media (GE Healthcare Life
Sciences, Pittsburgh, PA), followed by 5–10 s exposure to HyBlot
CL Autoradiography film (Denville Scientific, Metuchen, NJ).
The film was then developed.
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Confocal Immunofluorescence Microscopy of
Mammalian Cells
Fixed cells transfected with WT or mutant HA-SLC26A3
were blocked for 45min with 7% normal horse serum, then
incubated overnight at 4◦C with monoclonal anti-HA (1:300,
Cell Signaling Technologies), washed three times in PBS, then
incubated 1 h at room temperature with Alexa 546-coupled
goat anti-rabbit Ig (Life Technologies). After three final washes,
coverslips were inverted and mounted on glass slides using
VECTASHIELD mounting medium (Vector Labs, Burlingame,
CA). Other antigens were detected with compatible, species-
specific fluorophor-coupled secondary Ig. After fixation and
immunostaining of filter-grown cells as described above, the
filters were excised from their frames and mounted on glass
slides under coverslips with VECTASHIELD. Cells were imaged
with the Zeiss LSM510 confocal fluorescence microscope or
with the Nikon TE2000 inverted microscope interfaced to a
PerkinElmer spinning disk confocal unit and an Orca charge-
coupled device camera (Hamamatsu, Bridgewater, NJ). Image
processing was with Zeiss software or (for images captured
by Nikon-PerkinElmer microscope) with Slidebook (Intelligent
Imaging Innovations, Denver, CO).
Results
Clinical Data
The proband was a male infant, born in the setting of
polyhydramnios noted at gestational week 34. He exhibited
normal appetite and weight gain during the initial postnatal
weeks. At age 2 months he was hospitalized in a local Mexican
hospital with acute diarrhea requiring intravenous rehydration
therapy. Five additional hospitalizations for intravenous
rehydration treatment of diarrhea led to referral to Mexico
City’s Hospital Infantil for further evaluation. The patient
was found to have hypochloremic metabolic alkalosis with
hypokalemia and elevated serum levels of renin and aldosterone.
These abnormalities were responsive to intravenous fluid
therapy and a period of total parenteral nutrition. Infectious
causes of diarrhea were ruled out. Cystic fibrosis (CF) sweat
tests were negative on two occasions. Complete endoscopic
evaluation with biopsy revealed normal colonic mucosa by light
and electron microscopy, and normal gastric and duodenal
mucosae by light microscopy (data not shown). In the euvolemic
state, fecal [Cl−] was 160mM on two separate occasions. A
clinical diagnosis of congenital chloride-losing diarrhea was
made. After nearly 4 weeks of total parenteral nutrition, the
patient was weaned onto food supplemented with oral KCl
and NaCl, with subsequent acceleration of weight gain and
growth rate.
Molecular Diagnosis
SLC26A3 was considered a strong candidate gene for harboring a
coding mutation that might explain the chronic, severe diarrhea
of early onset in this child. DNA sequencing indeed revealed the
novel, homozygous SLC26A3mutation c.1177G>T encoding the
missense substitution p.Gly393Trp (G393W, Figure 1A). This
mutation was absent from the 1000 Genomes Project and from
the NHLBI Exome Project. The G393W mutation is predicted
to be “probably damaging” by PolyPhen-2 (scores 0.95 and
0.99 with two models). Amino acid residue G393 resides within
the polytopic transmembrane domain of SLC26A3 (Figure 1B).
Although the membrane domains of SLC26 polypeptides are
of unknown topographical disposition, hydropathy profiling has
predicted a location for G393 at the exofacial end of putative
transmembrane span 9 (Wedenoja et al., 2011). This residue is
conserved among SLC26A3 orthologs in primates, giant panda,
and rodents. However, G393 is substituted by Ala in pig, cow, and
sheep, and by Ser in dog, horse, and elephant (Figure 1C). The
residue is not conserved in X. laevis SLC26A3 or among human
SLC26 paralogs (not shown).
The patient was also homozygous for the common
synonymous single nucleotide polymorphism rs3735605
(c.1299G>A/p.Ala433Ala; minor allele frequency 0.159) and the
rare polymorphism rs41669 (c.1953T>C/p.Leu651Leu; minor
allele frequency 0.0023). Both parents were heterozygous for
G393W and for the two synonymous polymorphisms.
SLC26A3 G393W Exhibits Reduced Anion
Transport Function in Xenopus Oocytes
cRNA encoding SLC26A3 was transcribed and injected into
Xenopus oocytes. After 72 h, oocytes were subjected to
measurements of unidirectional 36Cl− influx. As shown in
Figure 2A, uptake of 36Cl− into oocytes injected with themutant
cRNA was reduced only slightly as compared to oocytes injected
with wildtype SLC26A3 cRNA. The measured 36Cl− uptake
operationally represented anion exchange, since 36Cl− eﬄux
mediated by both wildtype andmutant SLC26A3 exhibited trans-
anion dependence (Figures 2B,C). The 36Cl− eﬄux activity of
SLC26A3 G393W-expressing oocytes was reduced to a greater
degree than was influx into similarly injected oocytes. Oocytes
expressing SLC26A3 G393W mediated Cl−/HCO−3 exchange
at reduced rates (Figure 2D) proportionate to the reduction
in Cl−/Cl− exchange (Figure 2C). The reduction in transport
activity by SLC26A3 G393W was likely intrinsic to the mutant
polypeptide, since Xenopus oocyte surface expression of the HA-
tagged mutant polypeptide is undiminished compared to that of
wildtype SLC26A3 (Figure 3).
SL26A3 G393W Is Mistargeted and Fails to
Accumulate in HEK-293 Cells
The 35–80% decrease in anion transport function exhibited
in Xenopus oocytes is likely inadequate to account for the
severity of the proband’s clinical phenotype. We therefore
transiently expressed SLC26A3 G393W in HEK-293 cells. As
shown in Figures 4A,B, HA-tagged wildtype SLC26A3 localized
primarily to the cell periphery, whereas the HA-tagged mutant
polypeptide was detected in smaller numbers of cells, in which
it accumulated in a perinuclear distribution without reaching
the cell periphery (Figures 4C,D). Assessment of total SLC26A3
polypeptide accumulation by immunoblot of total cell lysates
(Figure 4E) revealed that the robust accumulation of wildtype
protein was not reproduced by the G393W mutant polypeptide,
which was below the immunoblot detection threshold. These
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FIGURE 1 | The novel SLC26A3 mutation G393W in a child with
chloride-losing diarrhea. (A) Genomic DNA Sequence phoretograms of
proband and parents. (B) Topographic model of hSLC26A3 (reproduced
from Wedenoja et al., 2011) showing the predicted location of G393 within
the transmembrane domain. (C) Alignment of mammalian SLC26A3
polypeptide sequences in the region of hSLC26A3 G393 (black box),
showing partial conservation among species orthologs, with substitutions
restricted to Ala and Ser (Polyphen-2 multiple sequence alignment).
results suggested that the G393W polypeptide is synthesized in
HEK-293 cells, but is unstable.
SLC26A3 G393W Accumulation Is Reduced and
Transient in Caco-2 Cells
Figure 5 shows that in small colonies of Caco-2 cells grown
on glass, at 24 h post-transfection, WT HA-SLC26A3 localizes
predominantly to the peripheral membrane, where it partially
colocalizes with E-cadherin, in addition to lesser accumulation
in a diffuse punctate distribution. In contrast, HA-SLC26A3
G393W exhibits only a diffuse punctate distribution at reduced
abundance.
However, as shown in Figure 6 (upper panels), 72 h post-
transfection of Caco-2 cells previously grown to confluence on
filter supports, WT-HA-SLC26A3 is concentrated at or near
the apical membrane, without colocalization with basolateral
marker Na,K-ATPase. Apical localization was occasional but less
reliable in confluent Caco-2 cells grown on glass (not shown)
Accumulation of HA-SLC26A3 G393W was barely if at all
detectable in similar confluentmonolayers of filter-grownCaco-2
cells (Figure 6, lower panels).
SLC26A3 G393W Fails to Accumulate in
Polarized MDCK Cells
Since mutant HA-SLC26A3 G393W failed to accumulate in
confluent Caco-2 cells on filters, we examined the mutant
protein’s localization in transiently transfected, confluent, filter-
grown MDCK cells.
As shown in Figure 7A, wildtype HA-SLC26A3 (red)
accumulated in the apical membrane of MDCK cells, a location
completely distinct from that of the basolaterally localized
Na,K-ATPase (green), but within the same membrane as
the endogenous apical marker gp135/podocalyxin (Figure 7B,
green). Transfection into polarized MDCK cell monolayers of
mutant HA-tagged SLC26A3 G393W cDNA yielded variable
results. On occasion, as shown in Figures 8B,D, HA-SLC26A3
G393W did accumulate at low levels throughout the cell, without
apparent exclusion from the apical membrane. But cells with
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FIGURE 2 | SLC26A3 mutant G393W expressed in Xenopus oocytes
exhibits modest loss-of-function. (A) 36Cl− influx into (n) uninjected
oocytes (uninj.) or oocytes previously injected with 10 ng cRNA encoding
hSLC26A3 WT (A3 WT) or its mutant hSLC26A3 G393W (A3 G393W).
WT and mutant did not differ as judged by One-Way ANOVA analysis,
but transport by G393W-expressing oocytes was significantly reduced as
judged by Student’s T-Test (p < 0.001). (B) 36Cl− efflux traces of
representative individual oocytes previously uninjected (Uninj, open circles)
or injected with 10 ng cRNA encoding hSLC26A3 WT (A3 WT, black
squares) or mutant hSLC26A3 G393W (A3 G393W, open triangles),
during sequential exposures to baths of sodium cyclamate (Na cyc.),
ND-96, and Na cyc. (C) Summarized 36Cl− efflux rate constant data
from (n) oocytes subjected to the protocol presented in (B). Values are
means ± s.e.m. *p < 0.05 vs. hSLC26A3 WT (One-Way ANOVA). (D)
Summarized 36Cl− efflux rate constant data from (n) uninjected oocytes
(Uninj.) or oocytes previously injected with 10 ng of cRNA encoding
hSLC26A3 WT or mutant G393W exposed first to 24mM NaHCO3 plus
72mM Na cyc (Cl−/HCO−3 exchange), followed by 96mM Na cyc.
36Cl−
efflux into HCO−3 solution, corrected for that into HCO
−
3 -free cyclamate
solution, did not differ statistically among groups.
any accumulation of the mutant polypeptide were unusual, and
contrasted to the exclusively apical localization of HA-SLC26A3
WT polypeptide (Figures 8A,C).
In confluent, semi-polarized MDCK cell monolayers
grown on glass, transiently transfected HA-SLC26A3 often
was dispersed throughout the cells without preferential
localization to either apical or basal peripheral membrane
(Figure 9A). However, transiently transfected mutant HA-
SLC26A3 G393W did not accumulate above barely detectable
levels in any cells observed (Figures 9B–D), likely reflecting
diminished mutant protein stability in the setting of the
relatively low transfection efficiency characteristic of MDCK
cells.
Transient transfection of cDNAs encoding HA-SLC26A3 WT
and G393W cDNAs into confluent LLC-PK1 monolayers
on glass similarly yielded barely detectable expression
of the mutant protein, despite apparent transfection
efficiencies of 30–40% as measured by GFP co-transfection
(not shown).
Discussion
We have presented a case of congenital chloride diarrhea (CLD)
in a child in whom we have documented the novel SLC26A3
missense mutation G393W. This is the first SLC26A3 mutation
reported fromMexico or from Latin America.
SLC26A3 mediates most of human intestinal apical
Cl−/HCO−3 exchange responsible for NHE3-coupled NaCl
reabsorption (Walker et al., 2008; Alper and Sharma, 2013).
Impairment or loss of this function is believed adequate to
explain the intestinal and systemic acid-base phenotypes of CLD
in neonates. Initial reports of successful treatment of CLD by
omeprazole or by sodium butyrate have not proven reproducible
in most patients, and lifelong replacement of ongoing fluid and
salt losses remains the mainstay of therapy.
SLC26A3 mediates nearly all electroneutral Cl−/HCO−3
exchange in mouse cecum (Alper et al., 2011), and a large
part of cecal sulfate/Cl− exchange (Whittamore et al., 2013). In
mouse duodenum, SLC26A3 contributes substantially to basal
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FIGURE 3 | SLC26A3 localization in Xenopus oocytes. Median intensity
examples of confocal immunofluorescence images of Xenopus oocytes
previously injected with 10 ng cRNA encoding (A) N-terminally HA-tagged
wildtype hSLC263, (B) HA-tagged hSLC26A3 mutant G393W, or (C)
oocytes previously uninjected with cRNA. (D) Mean values (± s.e.m.) of
normalized fluorescent intensity (FI) for (n) oocytes similar to those
presented in (A–C). FI did not differ between WT and mutant
hSLC26A3-expressing oocytes, but both differed from the uninjected group
(*p < 0.05).
Cl−/HCO−3 exchange activity, and to acid-stimulated HCO
−
3
secretion (Singh et al., 2013). In adult humans, deficiency of
acid-stimulated duodenal HCO−3 secretion has been linked to
duodenal ulcer, but duodenal ulcer has not been described even
as a late-onset feature of congenital chloride diarrhea. Mouse
SLC26A3 does notmediate duodenal HCO−3 secretion stimulated
by forskolin (Singh et al., 2013) or PGE2 (Tuo et al., 2006).
SLC26A3 expression leads to modest oxalate uptake into
Xenopus oocytes (Chernova et al., 2003), and its genetic
deficiency in mouse was recently shown to reduce luminal
uptake of oxalate in ileum, cecum, and distal colon of mouse
(Freel et al., 2013). However, other evidence strongly suggests
that murine intestinal oxalate absorption is mediated entirely
through paracellular pathways (Knauf et al., 2011). Interestingly,
the chronic renal insufficiency of congenital chloride diarrhea is
characterized by nephrocalcinosis (von Kossa-positive, and thus
likely calcium phosphate) without nephrolithiasis, in the absence
of serum oxalate abnormalities, hypercalciuria or hyperoxaluria.
The reappearance of nephrocalcinosis in the transplanted kidney
of a CLD patient, however, suggests that the renal calcification
reflected chronic systemic volume depletion and alkalosis rather
than an intrinsic renal defect (Wedenoja et al., 2008).
Our current results showed that in Xenopus oocytes,
SLC26A3 G393W is trafficked to and accumulates at the
plasma membrane, where it functions as a mild hypomorphic
mutant. However, in HEK-293 cells SLC26A3 G393W is retained
intracellularly in a pattern suggestive of endoplasmic reticulum
localization, and is greatly reduced in total abundance, without
FIGURE 4 | SLC26A3 localization in HEK-293 cells. HEK-293 cells
48 h after transient transfection with cDNA encoding HA-SLC26A3
wildtype (A,B) or mutant HA-SLC26A3 G393 (C,D). HA epitope is red,
and nuclei are stained with DAPI. (E) Immunoblot of whole cell RIPA
lysates from HEK-293 cells prepared 24 h post-transient transfection with
cDNA encoding HA-SLC26A3 wildtype (left two lanes) or mutant
HA-SLC26A3 G393W (right two lanes). Actin immunoblot serves as load
controls (below).
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FIGURE 5 | Localization of wildtype and mutant SLC26A3
polypeptides in nonconfluent, glass-grown Caco-2 cells. HA-SLC26A3
WT (upper panels) and HA-SLC26A3 G393G in subconfluent Caco-2 cells
on glass, 24 h post-transient transfection, Cells were stained as indicated
with anti-HA (left) and with anti-E-cadherin (middle). Merged images shown
at right. Scale bar, 10µm.
FIGURE 6 | Localization of wildtype and mutant SLC26A3
polypeptides in confluent, filter-grown Caco-2 cells. HA-SLC26A3
WT (upper panels) and HA-SLC26A3 G393G (lower panels) in
confluent Caco-2 cell monolayers grown on Transwell filters, 72 h
post-transient transfection. Cells were stained as indicated with
anti-HA, anti-α1-Na,K-ATPase, and phalloidin to detect F-actin.
Merged images (with F-actin pseudocolored) shown at right. Scale
bar, 10µm.
evident surface expression. The mutant phenotype of very low
protein accumulation was reproducible among several additional
epithelial cell lines. At 24 h post-transfection into subconfluent,
not-yet polarized Caco-2 colon carcinoma cells, HA-SLC26A3
WT is localized largely at the cell periphery and less so within
the cells, whereas HA-SLC26A3 G393W is largely retained inside
the cell. However, at 72 h post-transfection into confluent filter-
grown Caco-2 cells, HA-SLC26A3 WT is localized apically, but
HA-SLC26A3G393W is undetectable or present at levels near the
threshold of fluorescent detection.
In transiently transfected, polarized, confluent MDCK cells,
SLC26A3 polypeptide localizes preferentially to the apical
membrane in filter-grown cell monolayers. However, SLC26A3
polypeptide in glass-grown MDCK monolayers is distributed
in a pan-cellular punctate pattern suggestive of post-Golgi
structures, but with little or no surface expression at either
apical or basolateral membrane. Transient transfection of
mutant SLC26A3 G393W leads to severely reduced polypeptide
abundance in glass-grown MDCK cells, as judged by HA-tag
immunofluorescence.
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FIGURE 7 | Localization of wildtype SLC26A3 in filter-grown MDCK
cells. Confluent, filter-grown, MDCK monolayers 48 h after transient
transfection with cDNA encoding wildtype HA-SLC26A3. Fixed, permeabilized
cells were costained with anti-HA (red) and antibody to the endogenous
basolateral marker Na+,K+-ATPase (A, green) or to the endogenous apical
marker gp135/podocalyxin (B, green). The x-z images at top are sections
situated at the horizontal lines in the lower x-y panels. The x-y panels at
bottom are sections situated at the blue horizontal lines in the upper x-z
panels. Scale bars, 5µm.
FIGURE 8 | Localization of wildtype and mutant SLC26A3 polypeptides
in confluent, glass-grown MDCK cells. X-Z confocal sections (A,C) and
20◦-tilted Z stack of X-Y projections (B,D) of confluent glass-grown MDCK
monolayers HA-SLC26A3-WT (left panels) and mutant HA-SLC26A3 G393W
(Right panels), 72 h post-transient transfection. Anti-HA is shown in green,
nuclear stain DRAQ5 in red. Scale bar, 10µm.
Thus, trafficking and accumulation of both wildtype and
G393W mutant SLC26A3 exhibit substantial cell-type specificity
and growth condition specificity. In particular, whereas the
Xenopus oocyte traffics HA-SLC26A3 mutant G393W to the cell
surface, multiple mammalian cell types fail reliably to accumulate
the protein and to concentrate it at the plasma membrane. Apical
localization of even WT polypeptide is enhanced by growth
on permeable filter supports. The mechanisms underlying
these cell type and matrix-dependent differences in SLC26A3
mutant trafficking are not clear. However, differences between
FIGURE 9 | Localization of wildtype and mutant SLC26A3 in
glass-grown MDCK cells. Confluent, glass-grown MDCK monolayers 48 h
after transient transfection with (A) cDNA encoding wildtype HA-SLC26A3 or
with (B–D) cDNA encoding mutant HA-SLC26A3 G393W. Fixed,
permeabilized cells were costained with anti-HA (red) and antibody to
Na+,K+-ATPase (red). Nuclei are stained with DAPI. Location of x-z sections
with respect to x-y sections is as described for Figure 6. Scale bar 5µm.
heterologous membrane transporter trafficking in oocytes and
polarized mammalian cells have been noted previously for many
proteins (Moeller and Fenton, 2010), including AQP2, CFTR,
and AE1/SLC4A1 (Jarolim et al., 1998; Chu et al., 2013).
Little is known of the mechanism for biosynthetic delivery
and physiological retrieval and degradation of SLC26A3. SLC26
polypeptides have as yet been associated with no identified
β-subunits. Previous heterologous expression tests of subcellular
trafficking have also exhibited cell-type specificity. In polarized
MDCK cells, apical membrane surface expression of wildtype
SLC26A3 required N-glycosylation at least two of the four
consensus Asn residues, but surface expression in nonpolarized
CHO cells was independent of N-glycosylation (Hayashi and
Yamashita, 2012). The C-terminal PDZ recognition motif of
SLC26A3 was dispensable for surface expression and basal
function in Xenopus oocytes (Chernova et al., 2003) and for
acute inhibition by acidic pHi (Wedenoja et al., 2008; Hayashi
et al., 2009), but essential for SLC26A3 stimulation signals
that elevate intracellular [Ca2+] or activate phosphatidylinositol-
3-kinase (Lamprecht et al., 2009; Lissner et al., 2010). This
PDZ recognition motif of SLC26A3 bound to the third PDZ
domain of the cytoskeletal scaffold protein NHERF4 (Lee et al.,
2012), an interaction that reduced SLC26A3 surface expression.
The PDZ motif also recognized the additional PDZ domain
scaffold proteins PDZK1, E3KARP/ NHERF2, and IKEPP in
the context of apical lipid rafts, pharmacological disruption
of which decreased transporter abundance at the cell surface
(Lissner et al., 2010). The role of ubiquitination, and the relative
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roles of proteasomal and lysosomal pathways in the regulated
degradation of SLC26A3 remain unknown.
In the absence of a crystal structure for an SLC26
transmembrane domain, the location of G393 within the
polypeptide transmembrane domain is not known. However,
G393W is predicted to reside at the exofacial (carboxy-
terminal) end of putative transmembrane helix 9 based on
hydropathy prediction algorithms. The 45 CLD-associated
missense, frameshift, or nonsense mutations reported to date
include 28 in the transmembrane domain. The nearest to G393W
in the primary structure include G379A, V381Del, and S398F.
Nearby (nominally asymptomatic) cSNPs include S398T and
S405T. Disease mutations somewhat farther away in the linear
sequence include C343Y and D468V. Only 18% of coding
mutations in SLC26A3 have been found in the C-terminal
cytoplasmic section that includes the STAS domain.
Intestinal SLC26A3 mRNA has been reported to be
downregulated in ulcerative colitis and in the IL10 transgenic
colitis model (Yang et al., 1998; Lohi et al., 2002), but SLC26A3
protein levels in intestinal tissues of patients with ulcerative
colitis were unchanged (Lohi et al., 2002). Polymorphisms in the
SLC26A3 gene have been linked to ulcerative colitis in Japanese
and Korean patients (Asano et al., 2009; Yang et al., 2011), but
not to Crohn’s disease. Polymorphic variants of SLC26A3 have
also been linked to prognosis of patients with colon carcinoma
(Dalerba et al., 2011) and to neoadjuvant therapy resistance in
HER2-negative breast carcinoma (De Ronde et al., 2013).
What selective pressure might favor retention of SLC26A3
loss-of-function alleles? SLC26A3 has been shown to interact
with the CF transmembrane regulator CFTR. SLC26A3
hypomorphs with decreased intestinal chloride absorption might
in theory exhibit attenuated CF phenotypes in the presence of at
least some CFTR mutations, perhaps those of moderate severity.
However, a GWAS study of 3763 CF patients failed to reveal
SLC26A3 as a strong modifier gene for the neonatal intestinal
CF phenotype of meconium ileus. In contrast, the NHE3 gene
(encoding the NHE3 Na+/H+ exchanger functionally coupled
to SLC26A3) and the evolutionarily related SLC26A9 gene
(highly expressed in apical membrane of mouse stomach and
duodenum, Liu et al., 2015) were detected as CF meconium ileus
modifier genes (Sun et al., 2012).
The understudied native populations of Latin America may
offer new opportunity for discovery and investigation of novel
mutations in the SLC26A3 gene, and in other genetic regulators
and modifiers of intestinal salt reabsorption and secretion.
Elucidation of the physiological impact of these mutations on
the trafficking and function of SLC26A3 and its biochemical and
functional polypeptide partners in ion transport should offer new
paths to therapeutic intervention in the treatment of diarrheal
disease, and insights into trans-epithelial ion transport in other
organs.
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